Publication | Closed Access
Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma
107
Citations
36
References
2012
Year
The combination of circulating tumor-infiltrate (sCD163) and tumor-specific (sTARC) proteins is more informative than either marker alone as disease response biomarkers in early and advanced disease during first-line therapy for cHL.
| Year | Citations | |
|---|---|---|
Page 1
Page 1